Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]

Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC] was reported 8737 times

Drugs of the Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 BREAST CONSERVING SURGERY 29 0.0566
1 POSTMORTEM BLOOD DRUG LEVEL INCREASED 19 0.0509
2 OSMOLAR GAP INCREASED 4 0.0396
3 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 10 0.0285
4 NECROSIS ISCHAEMIC 12 0.0260
5 PERITONEAL PERFORATION 4 0.0242
6 ANTIDEPRESSANT DRUG LEVEL ABOVE THERAPEUTIC 5 0.0193
7 PATIENT DISSATISFACTION WITH DEVICE 4 0.0159
8 EXPOSURE VIA INGESTION 38 0.0150
9 ANION GAP ABNORMAL 4 0.0149
10 TOXICOLOGIC TEST ABNORMAL 9 0.0149
11 ACCIDENTAL DEATH 27 0.0145
12 FACET JOINT SYNDROME 46 0.0141
13 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 95 0.0140
14 COMPULSIVE SEXUAL BEHAVIOUR 11 0.0136
15 CORYNEBACTERIUM INFECTION 7 0.0131
16 NAIL OPERATION 5 0.0121
17 ACCIDENTAL OVERDOSE 406 0.0111
18 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 79 0.0110
19 DEEP VEIN THROMBOSIS POSTOPERATIVE 22 0.0110
20 PNEUMONIA STREPTOCOCCAL 12 0.0109
21 HYPERCHLORAEMIA 7 0.0109
22 PNEUMONIA NECROTISING 7 0.0108
23 OPIATES POSITIVE 5 0.0104
24 SUDDEN INFANT DEATH SYNDROME 5 0.0102
25 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 61 0.0100
26 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 12 0.0095
27 SWOLLEN JOINT COUNT INCREASED 30 0.0094
28 INFLUENZA A VIRUS TEST POSITIVE 4 0.0093
29 HYPERLEUKOCYTOSIS 8 0.0090
30 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 20 0.0089
31 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 5 0.0089
32 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0088
33 CLONUS 24 0.0088
34 DRUG ABUSE 729 0.0087
35 RHEUMATIC FEVER 38 0.0085
36 SEROTONIN SYNDROME 163 0.0085
37 HYPERREFLEXIA 29 0.0083
38 OBSTRUCTION 33 0.0083
39 CONDUCTION DISORDER 15 0.0082
40 ABORTION THREATENED 4 0.0080
41 PERIPHERAL VENOUS DISEASE 32 0.0078
42 GASTROINTESTINAL MUCOSAL DISORDER 5 0.0076
43 HOMICIDE 14 0.0076
44 ALBUMINURIA 4 0.0075
45 AUTOSCOPY 4 0.0074
46 C-REACTIVE PROTEIN ABNORMAL 47 0.0073
47 CYTOKINE STORM 5 0.0073
48 SUSPECTED SUICIDE 34 0.0072
49 STRESS AT WORK 8 0.0071
50 DISSOCIATIVE DISORDER 5 0.0069
51 SUPERIOR VENA CAVA SYNDROME 4 0.0066
52 TRACHEITIS 5 0.0066
53 MYDRIASIS 77 0.0060
54 ONYCHOMADESIS 25 0.0060
55 SUBSTANCE DEPENDENCE 4 0.0059
56 FEELING DRUNK 44 0.0059
57 ACCIDENTAL POISONING 8 0.0058
58 POISONING 71 0.0056
59 DUODENAL ULCER PERFORATION 42 0.0056
60 SLOW RESPONSE TO STIMULI 7 0.0054
61 FINGER DEFORMITY 26 0.0054
62 ONYCHOMYCOSIS 23 0.0052
63 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 37 0.0052
64 TOXIC ENCEPHALOPATHY 26 0.0051
65 HYPORESPONSIVE TO STIMULI 6 0.0051
66 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 26 0.0051
67 RHEUMATOID FACTOR POSITIVE 28 0.0048
68 ALVEOLITIS ALLERGIC 5 0.0048
69 RESPIRATORY RATE DECREASED 15 0.0048
70 ACCIDENTAL DRUG INTAKE BY CHILD 7 0.0046
71 NEPHROSCLEROSIS 5 0.0045
72 CARDIAC HYPERTROPHY 5 0.0045
73 X-RAY ABNORMAL 8 0.0045
74 BRADYPNOEA 12 0.0044
75 EXPOSURE TO TOXIC AGENT 14 0.0044
76 IMMUNE THROMBOCYTOPENIA 20 0.0044
77 PSYCHOTIC SYMPTOM 9 0.0044
78 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 28 0.0043
79 CATHETER SITE SWELLING 4 0.0043
80 COMPLETED SUICIDE 355 0.0043
81 TOXICITY TO VARIOUS AGENTS 702 0.0042
82 LABELLED DRUG-DRUG INTERACTION ISSUE 6 0.0041
83 EUPHORIC MOOD 42 0.0041
84 HELICOBACTER INFECTION 42 0.0041
85 LOGORRHOEA 14 0.0040
86 LIP DRY 36 0.0040
87 BURSITIS 48 0.0040
88 PRODUCT LABEL CONFUSION 23 0.0039
89 CONTRAINDICATION TO MEDICAL TREATMENT 6 0.0039
90 PNEUMONIA PSEUDOMONAL 6 0.0039
91 FOLLICULITIS 41 0.0039
92 QUADRIPLEGIA 8 0.0039
93 MUSCLE INJURY 32 0.0039
94 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 8 0.0039
95 DRUG TOXICITY 52 0.0038
96 BLEPHAROSPASM 24 0.0038
97 PUPILLARY REFLEX IMPAIRED 7 0.0038
98 ANION GAP INCREASED 5 0.0037
99 HEAD TITUBATION 5 0.0036
100 KLEBSIELLA SEPSIS 4 0.0035
101 DISLOCATION OF VERTEBRA 8 0.0035
102 CARDIO-RESPIRATORY ARREST 146 0.0035
103 MATERNAL EXPOSURE TIMING UNSPECIFIED 13 0.0035
104 HANGOVER 12 0.0034
105 DRUG WITHDRAWAL CONVULSIONS 6 0.0034
106 INFUSION SITE REACTION 10 0.0033
107 RESPIRATORY ARREST 92 0.0033
108 SUPERINFECTION 5 0.0033
109 INFUSION SITE WARMTH 4 0.0033
110 BREAST CANCER STAGE III 21 0.0032
111 BRONCHOPNEUMONIA 11 0.0032
112 HYPERTENSIVE HEART DISEASE 6 0.0032
113 INAPPROPRIATE AFFECT 5 0.0032
114 ANTICHOLINERGIC SYNDROME 5 0.0031
115 FULL BLOOD COUNT ABNORMAL 33 0.0031
116 IMMUNE RECONSTITUTION SYNDROME 4 0.0031
117 LICHENOID KERATOSIS 7 0.0031
118 HYPERTHERMIA 23 0.0030
119 PARADOXICAL DRUG REACTION 11 0.0030
120 GLYCOSURIA 4 0.0030
121 PEMPHIGUS 37 0.0030
122 RESPIRATORY DEPRESSION 36 0.0029
123 INTENTIONAL OVERDOSE 188 0.0029
124 INFUSION SITE RASH 4 0.0029
125 STARING 7 0.0029
126 NAIL DISORDER 25 0.0029
127 EOSINOPHILIA 50 0.0029
128 OVERDOSE 615 0.0028
129 GRIP STRENGTH DECREASED 25 0.0028
130 HAND DEFORMITY 37 0.0028
131 DRUG SCREEN POSITIVE 22 0.0028
132 COELIAC DISEASE 27 0.0027
133 SKIN ABRASION 13 0.0027
134 AORTIC ARTERIOSCLEROSIS 7 0.0027
135 EYE INJURY 8 0.0026
136 MIOSIS 21 0.0026
137 BACK INJURY 28 0.0026
138 SUBSTANCE USE 4 0.0026
139 AUTOIMMUNE DISORDER 25 0.0026
140 JOINT RANGE OF MOTION DECREASED 34 0.0025
141 LIVER INJURY 62 0.0025
142 MYOPIA 6 0.0025
143 OXYGEN CONSUMPTION INCREASED 6 0.0025
144 MUCOSAL DRYNESS 5 0.0025
145 INCOHERENT 16 0.0025
146 EAR HAEMORRHAGE 5 0.0025
147 OBESITY 39 0.0024
148 PSYCHOMOTOR HYPERACTIVITY 40 0.0024
149 ALLERGY TO CHEMICALS 3 0.0024
150 SINUS DISORDER 47 0.0024
151 PULMONARY CONGESTION 31 0.0023
152 ACUTE SINUSITIS 4 0.0023
153 CATHETER SITE PAIN 6 0.0023
154 OTORRHOEA 4 0.0023
155 PSEUDOMONAL SEPSIS 4 0.0023
156 INFUSION SITE DISCHARGE 4 0.0023
157 HYPERCHOLESTEROLAEMIA 22 0.0023
158 RETROPERITONEAL HAEMATOMA 5 0.0023
159 PERICARDITIS 38 0.0023
160 PRODUCT LOT NUMBER ISSUE 5 0.0023
161 AREFLEXIA 6 0.0022
162 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 38 0.0022
163 PRODUCT TASTE ABNORMAL 30 0.0022
164 NON-CARDIAC CHEST PAIN 7 0.0022
165 DRUG USE DISORDER 18 0.0021
166 SYNOVITIS 38 0.0021
167 ATAXIA 25 0.0021
168 FIBROMYALGIA 51 0.0021
169 HYPERTONIC BLADDER 6 0.0021
170 ABDOMINAL WALL HAEMATOMA 4 0.0020
171 ADVERSE REACTION 27 0.0020
172 LIVE BIRTH 17 0.0020
173 ABDOMINAL TENDERNESS 10 0.0020
174 MYOCLONUS 24 0.0020
175 OESOPHAGEAL CANDIDIASIS 8 0.0020
176 INCORRECT PRODUCT ADMINISTRATION DURATION 43 0.0020
177 FOAMING AT MOUTH 4 0.0020
178 INJECTION SITE NECROSIS 4 0.0020
179 DRUG ABUSER 12 0.0020
180 SELF-MEDICATION 8 0.0019
181 UNRESPONSIVE TO STIMULI 50 0.0019
182 FAILURE TO THRIVE 10 0.0019
183 WOUND INFECTION 21 0.0019
184 PHYSICAL ASSAULT 4 0.0019
185 VENTRICULAR ARRHYTHMIA 7 0.0019
186 PRODUCTIVE COUGH 90 0.0019
187 NYSTAGMUS 10 0.0019
188 PNEUMONIA VIRAL 6 0.0019
189 CATHETER SITE ERYTHEMA 4 0.0019
190 HYPERTRANSAMINASAEMIA 13 0.0019
191 IRRITABLE BOWEL SYNDROME 40 0.0019
192 EXPIRED PRODUCT ADMINISTERED 62 0.0019
193 SUBSTANCE ABUSE 15 0.0018
194 GLOSSODYNIA 41 0.0018
195 PLEURITIC PAIN 5 0.0018
196 ARTERIOSCLEROSIS CORONARY ARTERY 12 0.0018
197 MENISCUS INJURY 11 0.0018
198 INCORRECT DRUG ADMINISTRATION DURATION 50 0.0018
199 INTENTIONAL DRUG MISUSE 37 0.0018
200 LEUKOCYTOSIS 32 0.0018
201 PUSTULAR PSORIASIS 6 0.0017
202 HALLUCINATION 129 0.0017
203 SEASONAL ALLERGY 24 0.0017
204 CONTRAINDICATED PRODUCT ADMINISTERED 51 0.0017
205 COMA 80 0.0017
206 GAIT INABILITY 56 0.0017
207 CHEILITIS 9 0.0017
208 ATELECTASIS 16 0.0017
209 MENTAL IMPAIRMENT 40 0.0016
210 ASPIRATION 18 0.0016
211 DEPRESSED LEVEL OF CONSCIOUSNESS 65 0.0016
212 DRUG LEVEL INCREASED 27 0.0016
213 WHEEZING 96 0.0016
214 SMALL FOR DATES BABY 8 0.0016
215 HALLUCINATION, VISUAL 34 0.0016
216 RESPIRATORY DISORDER 48 0.0016
217 PERSECUTORY DELUSION 4 0.0016
218 DERMATITIS EXFOLIATIVE 8 0.0016
219 NASAL DRYNESS 10 0.0016
220 AGITATION 117 0.0016
221 INFUSION SITE PRURITUS 5 0.0016
222 RESPIRATORY RATE INCREASED 14 0.0016
223 SUBSTANCE USE DISORDER 5 0.0016
224 IRON DEFICIENCY 7 0.0016
225 STUPOR 5 0.0016
226 THERAPEUTIC PRODUCT INEFFECTIVE 6 0.0016
227 ALCOHOL INTERACTION 3 0.0015
228 WOUND 43 0.0015
229 ENERGY INCREASED 9 0.0015
230 CATATONIA 8 0.0015
231 DRUG INTERACTION 240 0.0015
232 MAJOR DEPRESSION 11 0.0015
233 DELIRIUM 52 0.0015
234 POTENTIATING DRUG INTERACTION 5 0.0015
235 PNEUMONIA ASPIRATION 37 0.0015
236 ULCER HAEMORRHAGE 10 0.0015
237 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 77 0.0015
238 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 13 0.0015
239 INITIAL INSOMNIA 15 0.0015
240 JOINT EFFUSION 10 0.0014
241 PARANOIA 25 0.0014
242 SOCIAL PROBLEM 6 0.0014
243 MENTAL STATUS CHANGES 40 0.0014
244 NECROSIS 8 0.0014
245 IMPAIRED HEALING 47 0.0014
246 INFUSION SITE SWELLING 9 0.0014
247 TYPE 2 DIABETES MELLITUS 48 0.0014
248 JOINT DISLOCATION 15 0.0014
249 DISORIENTATION 56 0.0014
250 GASTROINTESTINAL SOUNDS ABNORMAL 7 0.0014
251 OXYGEN SATURATION ABNORMAL 4 0.0014
252 LIVER FUNCTION TEST INCREASED 30 0.0014
253 CARDIAC ARREST 115 0.0014
254 FACIAL BONES FRACTURE 5 0.0014
255 SUICIDE ATTEMPT 84 0.0014
256 DRUG TOLERANCE 7 0.0014
257 DYSPNOEA AT REST 4 0.0014
258 NO ADVERSE EVENT 249 0.0014
259 LUMBAR SPINAL STENOSIS 4 0.0014
260 NEUROLEPTIC MALIGNANT SYNDROME 16 0.0013
261 WRONG DRUG ADMINISTERED 12 0.0013
262 METABOLIC ACIDOSIS 43 0.0013
263 POLYURIA 11 0.0013
264 SCIATICA 21 0.0013
265 THERAPY NON-RESPONDER 59 0.0013
266 COMMUNICATION DISORDER 5 0.0013
267 SLEEP DISORDER 92 0.0013
268 COUGH 360 0.0013
269 CARDIOPULMONARY FAILURE 5 0.0013
270 TASTE DISORDER 26 0.0013
271 MULTIPLE ALLERGIES 10 0.0013
272 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 61 0.0013
273 CHOKING SENSATION 7 0.0013
274 SINUS TACHYCARDIA 18 0.0013
275 PNEUMONIA FUNGAL 5 0.0013
276 POISONING DELIBERATE 12 0.0013
277 SPUTUM DISCOLOURED 12 0.0013
278 VIRAL UPPER RESPIRATORY TRACT INFECTION 6 0.0013
279 FEELING JITTERY 24 0.0013
280 RASH MACULO-PAPULAR 28 0.0013
281 DRUG-INDUCED LIVER INJURY 39 0.0012
282 CARDIOMEGALY 15 0.0012
283 DRUG INEFFECTIVE 1604 0.0012
284 TACHYCARDIA 108 0.0012
285 PRODUCT FORMULATION ISSUE 8 0.0012
286 ABNORMAL BEHAVIOUR 48 0.0012
287 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 86 0.0012
288 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 86 0.0012
289 ELECTROLYTE IMBALANCE 14 0.0012
290 ANXIETY DISORDER 4 0.0012
291 HYPOVOLAEMIA 7 0.0012
292 NASAL CONGESTION 70 0.0012
293 BRAIN OEDEMA 15 0.0012
294 SOMNOLENCE 238 0.0012
295 SUDDEN CARDIAC DEATH 4 0.0012
296 EYE MOVEMENT DISORDER 8 0.0012
297 INFUSION SITE PAIN 15 0.0012
298 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 3 0.0012
299 SYSTEMIC LUPUS ERYTHEMATOSUS 41 0.0012
300 CHAPPED LIPS 5 0.0012
301 MENTAL DISORDER 50 0.0011
302 COAGULOPATHY 19 0.0011
303 ATRIAL FLUTTER 9 0.0011
304 RETCHING 24 0.0011
305 SINUSITIS 115 0.0011
306 ALCOHOL POISONING 3 0.0011
307 ABDOMINAL MASS 3 0.0011
308 DYSARTHRIA 42 0.0011
309 NORMAL NEWBORN 6 0.0011
310 HYDROCEPHALUS 6 0.0011
311 SCLERODERMA 4 0.0011
312 DRUG LEVEL ABOVE THERAPEUTIC 5 0.0011
313 PNEUMONIA BACTERIAL 10 0.0011
314 DRY THROAT 11 0.0011
315 LEUKOENCEPHALOPATHY 4 0.0011
316 DRUG EFFECT INCOMPLETE 39 0.0011
317 PULMONARY OEDEMA 48 0.0011
318 INFUSION SITE ERYTHEMA 9 0.0011
319 RESTLESSNESS 39 0.0011
320 UPPER RESPIRATORY TRACT INFECTION 49 0.0011
321 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 31 0.0011
322 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 18 0.0010
323 PSEUDOMONAS INFECTION 9 0.0010
324 LETHARGY 60 0.0010
325 AGGRESSION 52 0.0010
326 DIZZINESS 516 0.0010
327 RASH VESICULAR 5 0.0010
328 PRODUCT LABEL ISSUE 7 0.0010
329 NIGHT SWEATS 33 0.0010
330 RENAL CELL CARCINOMA 5 0.0010
331 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
332 HEPATITIS 26 0.0010
333 PSYCHOTIC DISORDER 30 0.0010
334 ALTERED STATE OF CONSCIOUSNESS 22 0.0010
335 HEPATIC CIRRHOSIS 19 0.0010
336 BLOOD CHOLESTEROL INCREASED 47 0.0010
337 ARTHROPATHY 56 0.0010
338 CONFUSIONAL STATE 161 0.0010
339 DISSEMINATED INTRAVASCULAR COAGULATION 14 0.0010
340 LOWER LIMB FRACTURE 19 0.0010
341 HEPATOTOXICITY 22 0.0010
342 DRY MOUTH 80 0.0010
343 INTENTIONAL PRODUCT MISUSE 86 0.0010
344 BLISTER 55 0.0010
345 INCREASED UPPER AIRWAY SECRETION 5 0.0010
346 ANAPHYLACTOID REACTION 4 0.0010
347 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 6 0.0010
348 ERYTHEMA MULTIFORME 9 0.0010
349 VENTRICULAR EXTRASYSTOLES 10 0.0010
350 SINUS CONGESTION 13 0.0010
351 SECRETION DISCHARGE 12 0.0010
352 HALLUCINATIONS, MIXED 4 0.0010
353 SUDDEN DEATH 10 0.0009
354 PULMONARY FIBROSIS 18 0.0009
355 INFLAMMATION 48 0.0009
356 VITAMIN D DEFICIENCY 9 0.0009
357 OCULAR ICTERUS 4 0.0009
358 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
359 TROPONIN INCREASED 7 0.0009
360 LUNG DISORDER 45 0.0009
361 RHINORRHOEA 59 0.0009
362 HEPATIC STEATOSIS 17 0.0009
363 DYSPHEMIA 4 0.0009
364 PSORIATIC ARTHROPATHY 37 0.0009
365 WALKING AID USER 6 0.0009
366 TREMOR 151 0.0009
367 INSOMNIA 239 0.0009
368 POST-TRAUMATIC STRESS DISORDER 6 0.0009
369 STOMATITIS 54 0.0009
370 INFUSION RELATED REACTION 59 0.0009
371 ELECTROCARDIOGRAM QT PROLONGED 32 0.0009
372 RHABDOMYOLYSIS 37 0.0009
373 ACUTE RESPIRATORY FAILURE 17 0.0009
374 RESPIRATORY TRACT INFECTION 23 0.0009
375 LOWER RESPIRATORY TRACT INFECTION 40 0.0009
376 HYPERTONIA 5 0.0009
377 OSTEOARTHRITIS 37 0.0009
378 RESPIRATION ABNORMAL 6 0.0009
379 PRODUCT COMPLAINT 22 0.0009
380 ASTHMA 98 0.0009
381 SYNOVIAL CYST 4 0.0009
382 NEPHROGENIC ANAEMIA 4 0.0009
383 HAEMOPTYSIS 24 0.0009
384 ENCEPHALOPATHY 21 0.0009
385 HYPOXIA 30 0.0009
386 MANIA 14 0.0009
387 EPILEPSY 26 0.0008
388 HIATUS HERNIA 11 0.0008
389 BRONCHOSPASM 12 0.0008
390 SUBDURAL HAEMATOMA 12 0.0008
391 MUSCLE RIGIDITY 10 0.0008
392 FAECAL INCONTINENCE 4 0.0008
393 BIPOLAR DISORDER 9 0.0008
394 FEELING ABNORMAL 195 0.0008
395 ALCOHOL USE 3 0.0008
396 HYPERVOLAEMIA 4 0.0008
397 ABDOMINAL PAIN UPPER 166 0.0008
398 PHARYNGITIS 10 0.0008
399 AKATHISIA 11 0.0008
400 MULTIPLE DRUG OVERDOSE 4 0.0008
401 NECK PAIN 45 0.0008
402 MUSCULOSKELETAL PAIN 42 0.0008
403 HYPERAMMONAEMIA 4 0.0008
404 BRAIN INJURY 8 0.0008
405 STATUS EPILEPTICUS 9 0.0008
406 HYPOAESTHESIA ORAL 12 0.0008
407 MITRAL VALVE INCOMPETENCE 9 0.0008
408 DIARRHOEA 513 0.0008
409 EMPHYSEMA 8 0.0008
410 INTENTIONAL SELF-INJURY 16 0.0008
411 IMPAIRED DRIVING ABILITY 9 0.0008
412 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 4 0.0008
413 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
414 CARPAL TUNNEL SYNDROME 11 0.0008
415 SCREAMING 5 0.0008
416 CARDIOTOXICITY 7 0.0008
417 INSURANCE ISSUE 12 0.0008
418 DISSOCIATION 6 0.0008
419 LOSS OF LIBIDO 7 0.0008
420 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 20 0.0008
421 HYPOAESTHESIA 116 0.0008
422 ILL-DEFINED DISORDER 47 0.0008
423 DYSTONIA 15 0.0008
424 PNEUMONIA 250 0.0008
425 LUPUS-LIKE SYNDROME 7 0.0008
426 INJURY 54 0.0008
427 EXOSTOSIS 7 0.0008
428 ROAD TRAFFIC ACCIDENT 32 0.0008
429 WEIGHT FLUCTUATION 8 0.0008
430 ASPERGILLUS INFECTION 5 0.0008
431 HYPERSENSITIVITY 141 0.0008
432 GASTROOESOPHAGEAL REFLUX DISEASE 61 0.0008
433 NASAL DISCOMFORT 6 0.0008
434 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
435 CHEST DISCOMFORT 77 0.0008
436 CARDIAC FAILURE ACUTE 5 0.0007
437 HEART RATE INCREASED 74 0.0007
438 BRONCHIECTASIS 5 0.0007
439 NEUROTOXICITY 13 0.0007
440 STRESS FRACTURE 4 0.0007
441 SHOCK HAEMORRHAGIC 6 0.0007
442 THERAPEUTIC PRODUCT EFFECT DECREASED 33 0.0007
443 TACHYPNOEA 10 0.0007
444 SEPTIC SHOCK 32 0.0007
445 HEAD DISCOMFORT 13 0.0007
446 NERVOUSNESS 38 0.0007
447 LOSS OF CONSCIOUSNESS 93 0.0007
448 GASTROINTESTINAL DISORDER 65 0.0007
449 ANXIETY 206 0.0007
450 FEBRILE NEUTROPENIA 48 0.0007
451 PRESCRIBED OVERDOSE 14 0.0007
452 RED BLOOD CELL SEDIMENTATION RATE INCREASED 8 0.0007
453 HYPOTHYROIDISM 23 0.0007
454 EAR PAIN 14 0.0007
455 PULMONARY HYPERTENSION 15 0.0007
456 STREPTOCOCCAL INFECTION 4 0.0007
457 HEPATIC ENZYME INCREASED 49 0.0007
458 HEART RATE ABNORMAL 4 0.0007
459 DYSPNOEA EXERTIONAL 27 0.0007
460 RESTLESS LEGS SYNDROME 13 0.0007
461 RENAL TUBULAR NECROSIS 7 0.0007
462 END STAGE RENAL DISEASE 13 0.0007
463 OXYGEN SATURATION DECREASED 40 0.0007
464 BODY TEMPERATURE DECREASED 7 0.0007
465 DELUSION 11 0.0007
466 HYPERTENSION 149 0.0007
467 THROAT TIGHTNESS 19 0.0007
468 DERMATITIS CONTACT 8 0.0007
469 ALCOHOLISM 3 0.0007
470 NASOPHARYNGITIS 128 0.0007
471 TUBULOINTERSTITIAL NEPHRITIS 13 0.0007
472 PANIC REACTION 5 0.0007
473 PYELONEPHRITIS 6 0.0007
474 RESPIRATORY TRACT CONGESTION 11 0.0007
475 LIP SWELLING 23 0.0007
476 HYPERVENTILATION 4 0.0007
477 RESPIRATORY DISTRESS 19 0.0007
478 C-REACTIVE PROTEIN INCREASED 25 0.0007
479 HYPERGLYCAEMIA 25 0.0007
480 CONTUSION 66 0.0007
481 CONDITION AGGRAVATED 208 0.0007
482 UTERINE LEIOMYOMA 5 0.0007
483 SWELLING 64 0.0007
484 SPINAL OSTEOARTHRITIS 6 0.0007
485 DYSPEPSIA 67 0.0007
486 ARTHROPOD BITE 5 0.0007
487 PLEURISY 4 0.0007
488 SINUS HEADACHE 4 0.0007
489 URTICARIA 112 0.0007
490 GENERAL SYMPTOM 5 0.0007
491 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 120 0.0007
492 BLOOD POTASSIUM DECREASED 20 0.0007
493 TYPE 1 DIABETES MELLITUS 4 0.0007
494 TOOTHACHE 12 0.0007
495 ECONOMIC PROBLEM 10 0.0007
496 EXPOSURE DURING PREGNANCY 41 0.0007
497 OSTEOPENIA 10 0.0007
498 ABDOMINAL DISCOMFORT 110 0.0007
499 MOBILITY DECREASED 47 0.0007
500 HIP ARTHROPLASTY 10 0.0007
501 DYSSTASIA 19 0.0007
502 SEDATION 17 0.0006
503 HYPOMAGNESAEMIA 9 0.0006
504 APHONIA 9 0.0006
505 SKIN LACERATION 7 0.0006
506 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
507 PRE-EXISTING CONDITION IMPROVED 4 0.0006
508 DISCOMFORT 39 0.0006
509 HYPERHIDROSIS 82 0.0006
510 LYMPHOPENIA 9 0.0006
511 BRONCHITIS 47 0.0006
512 BLOOD PRESSURE INCREASED 97 0.0006
513 RESPIRATORY FAILURE 46 0.0006
514 MEDICATION ERROR 35 0.0006
515 HALLUCINATION, AUDITORY 10 0.0006
516 TRICUSPID VALVE INCOMPETENCE 5 0.0006
517 SLEEP APNOEA SYNDROME 12 0.0006
518 MUSCULOSKELETAL STIFFNESS 55 0.0006
519 CORONARY ARTERY DISEASE 19 0.0006
520 COLD SWEAT 11 0.0006
521 PARAESTHESIA ORAL 9 0.0006
522 FEELING HOT 38 0.0006
523 PRESYNCOPE 15 0.0006
524 IRRITABILITY 37 0.0006
525 BACK DISORDER 10 0.0006
526 VOMITING 289 0.0006
527 DECUBITUS ULCER 5 0.0006
528 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
529 DRUG INTOLERANCE 59 0.0006
530 HOSPICE CARE 6 0.0006
531 BLOOD PRESSURE ABNORMAL 12 0.0006
532 HYPOTONIA 6 0.0006
533 VIRAL INFECTION 20 0.0006
534 FAECES DISCOLOURED 13 0.0006
535 CHOLECYSTITIS CHRONIC 4 0.0006
536 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
537 COLITIS ISCHAEMIC 4 0.0006
538 EXTRA DOSE ADMINISTERED 24 0.0006
539 WRONG PRODUCT ADMINISTERED 4 0.0006
540 THINKING ABNORMAL 11 0.0006
541 OEDEMA 32 0.0006
542 FLUID RETENTION 30 0.0006
543 BODY TEMPERATURE INCREASED 12 0.0006
544 LIVER DISORDER 26 0.0006
545 INTENTIONAL PRODUCT USE ISSUE 51 0.0006
546 DROOLING 4 0.0006
547 GASTRIC ULCER 11 0.0006
548 LYMPHOEDEMA 4 0.0006
549 DIPLOPIA 15 0.0006
550 EYE DISCHARGE 6 0.0006
551 NOCTURIA 7 0.0006
552 AUTOIMMUNE HEPATITIS 4 0.0006
553 ORTHOSTATIC HYPOTENSION 10 0.0006
554 INCONTINENCE 6 0.0006
555 PNEUMOTHORAX 9 0.0006
556 TINNITUS 26 0.0006
557 DYSPNOEA 318 0.0006
558 MYOSITIS 5 0.0006
559 DECREASED ACTIVITY 6 0.0006
560 PNEUMONITIS 15 0.0006
561 PREGNANCY 11 0.0005
562 LIQUID PRODUCT PHYSICAL ISSUE 4 0.0005
563 MOUTH HAEMORRHAGE 4 0.0005
564 FOOT DEFORMITY 6 0.0005
565 URINARY INCONTINENCE 16 0.0005
566 PRODUCT DISTRIBUTION ISSUE 5 0.0005
567 VISION BLURRED 74 0.0005
568 BLOOD UREA INCREASED 9 0.0005
569 PULMONARY MASS 8 0.0005
570 IMMUNODEFICIENCY 8 0.0005
571 MALNUTRITION 6 0.0005
572 DEPRESSION 122 0.0005
573 DIARRHOEA HAEMORRHAGIC 5 0.0005
574 THROAT IRRITATION 24 0.0005
575 PANCREATITIS ACUTE 12 0.0005
576 CHROMATURIA 12 0.0005
577 HEART RATE IRREGULAR 12 0.0005
578 TOOTH INFECTION 7 0.0005
579 REBOUND EFFECT 6 0.0005
580 JOINT SWELLING 64 0.0005
581 UNEVALUABLE EVENT 40 0.0005
582 FOOT FRACTURE 10 0.0005
583 ACIDOSIS 4 0.0005
584 PANIC ATTACK 19 0.0005
585 GENERAL PHYSICAL HEALTH DETERIORATION 60 0.0005
586 OROPHARYNGEAL PAIN 48 0.0005
587 MUSCULOSKELETAL CHEST PAIN 8 0.0005
588 CELLULITIS 26 0.0005
589 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
590 DIZZINESS POSTURAL 5 0.0005
591 THERAPEUTIC RESPONSE UNEXPECTED 23 0.0005
592 EYE SWELLING 19 0.0005
593 BRAIN FOG 8 0.0005
594 TORSADE DE POINTES 4 0.0005
595 PERIPHERAL COLDNESS 7 0.0005
596 AFFECTIVE DISORDER 4 0.0005
597 PRODUCT USE IN UNAPPROVED INDICATION 126 0.0005
598 COVID-19 PNEUMONIA 6 0.0005
599 AMNESIA 33 0.0005
600 PALPITATIONS 59 0.0005
601 GINGIVAL PAIN 4 0.0005
602 ACCIDENT 6 0.0005
603 WITHDRAWAL SYNDROME 21 0.0005
604 SALIVARY HYPERSECRETION 5 0.0005
605 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
606 SKIN REACTION 7 0.0005
607 SPEECH DISORDER 26 0.0005
608 TRANSAMINASES INCREASED 11 0.0005
609 ANHEDONIA 13 0.0005
610 LACTIC ACIDOSIS 16 0.0005
611 GAIT DISTURBANCE 94 0.0005
612 COVID-19 86 0.0005
613 PARAESTHESIA 77 0.0005
614 HYPOTENSION 98 0.0005
615 EAR DISCOMFORT 5 0.0005
616 ASTHENIA 183 0.0005
617 EYE DISORDER 16 0.0005
618 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
619 SPINAL COMPRESSION FRACTURE 4 0.0005
620 BACTERIAL INFECTION 9 0.0005
621 MIGRAINE 46 0.0005
622 BREAST CANCER STAGE II 4 0.0005
623 CHEST PAIN 89 0.0005
624 PERIPHERAL SWELLING 74 0.0005
625 PYREXIA 166 0.0005
626 MALAISE 210 0.0005
627 PHOTOPHOBIA 9 0.0005
628 DECREASED APPETITE 111 0.0005
629 BLOOD SODIUM DECREASED 9 0.0005
630 OEDEMA PERIPHERAL 58 0.0005
631 KNEE ARTHROPLASTY 10 0.0005
632 CANDIDA INFECTION 8 0.0005
633 ACUTE KIDNEY INJURY 72 0.0005
634 ABDOMINAL DISTENSION 49 0.0005
635 ABDOMINAL PAIN 109 0.0005
636 EPISTAXIS 35 0.0005
637 POOR QUALITY SLEEP 10 0.0005
638 DISTURBANCE IN ATTENTION 25 0.0005
639 HEADACHE 290 0.0005
640 DYSURIA 17 0.0005
641 BLOOD COUNT ABNORMAL 7 0.0005
642 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
643 OESOPHAGITIS 5 0.0005
644 PRODUCT USE ISSUE 86 0.0005
645 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
646 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 25 0.0005
647 DISABILITY 9 0.0005
648 THERAPEUTIC RESPONSE SHORTENED 15 0.0005
649 BLOOD PRESSURE DECREASED 30 0.0005
650 SWOLLEN TONGUE 14 0.0004
651 GASTROINTESTINAL INFECTION 4 0.0004
652 SKIN INFECTION 5 0.0004
653 OCULAR DISCOMFORT 5 0.0004
654 ANAL INCONTINENCE 4 0.0004
655 GASTROENTERITIS VIRAL 8 0.0004
656 DYSKINESIA 18 0.0004
657 EYE INFECTION 5 0.0004
658 NAUSEA 350 0.0004
659 PALLOR 12 0.0004
660 ABNORMAL LOSS OF WEIGHT 3 0.0004
661 BALANCE DISORDER 38 0.0004
662 MYOCARDIAL ISCHAEMIA 5 0.0004
663 OSTEOPOROSIS 18 0.0004
664 NEPHROLITHIASIS 20 0.0004
665 INCREASED TENDENCY TO BRUISE 4 0.0004
666 TREATMENT FAILURE 36 0.0004
667 CHRONIC KIDNEY DISEASE 33 0.0004
668 GRAND MAL CONVULSION 4 0.0004
669 RHEUMATOID ARTHRITIS 49 0.0004
670 ATRIAL FIBRILLATION 42 0.0004
671 FEELING COLD 12 0.0004
672 COORDINATION ABNORMAL 6 0.0004
673 SYNCOPE 43 0.0004
674 LACERATION 4 0.0004
675 EATING DISORDER 9 0.0004
676 INJECTION SITE REACTION 29 0.0004
677 BACTERAEMIA 5 0.0004
678 PRODUCT PACKAGING ISSUE 4 0.0004
679 INTENTIONAL DOSE OMISSION 12 0.0004
680 DISEASE RECURRENCE 20 0.0004
681 FUNGAL INFECTION 14 0.0004
682 CHOLECYSTITIS 5 0.0004
683 HYPERLIPIDAEMIA 5 0.0004
684 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
685 IMPAIRED QUALITY OF LIFE 6 0.0004
686 ANAPHYLACTIC REACTION 23 0.0004
687 BRADYCARDIA 22 0.0004
688 ANOSMIA 6 0.0004
689 MUSCLE SPASMS 76 0.0004
690 EAR INFECTION 11 0.0004
691 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
692 SEPSIS 46 0.0004
693 ADRENAL INSUFFICIENCY 5 0.0004
694 CYTOPENIA 5 0.0004
695 CONSTIPATION 89 0.0004
696 DEATH 351 0.0004
697 WEIGHT INCREASED 91 0.0004
698 STEVENS-JOHNSON SYNDROME 9 0.0004
699 SKIN HAEMORRHAGE 6 0.0004
700 TOOTH DISORDER 9 0.0004
701 MATERNAL EXPOSURE DURING PREGNANCY 36 0.0004
702 BLADDER DISORDER 4 0.0004
703 EXTRAPYRAMIDAL DISORDER 10 0.0004
704 CONVULSION 23 0.0004
705 CYTOKINE RELEASE SYNDROME 8 0.0004
706 HEPATIC FAILURE 12 0.0004
707 UNDERDOSE 29 0.0004
708 CHOLELITHIASIS 13 0.0004
709 HYPOTHERMIA 4 0.0004
710 INFECTION 57 0.0004
711 PANCYTOPENIA 22 0.0004
712 TOOTH ABSCESS 4 0.0004
713 SHOCK 9 0.0004
714 PHARYNGEAL OEDEMA 6 0.0004
715 SEIZURE 45 0.0004
716 PERICARDIAL EFFUSION 9 0.0004
717 RIB FRACTURE 8 0.0004
718 ANKLE FRACTURE 6 0.0004
719 FATIGUE 300 0.0004
720 THERAPY PARTIAL RESPONDER 6 0.0004
721 TENDERNESS 4 0.0004
722 PETECHIAE 4 0.0004
723 CYANOSIS 6 0.0004
724 PRODUCT USE COMPLAINT 6 0.0004
725 GASTRITIS 10 0.0004
726 SCRATCH 4 0.0004
727 ASPARTATE AMINOTRANSFERASE INCREASED 20 0.0004
728 ALANINE AMINOTRANSFERASE INCREASED 23 0.0004
729 QUALITY OF LIFE DECREASED 5 0.0004
730 RASH MACULAR 13 0.0004
731 MEMORY IMPAIRMENT 51 0.0004
732 ABNORMAL FAECES 3 0.0004
733 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
734 TREATMENT NONCOMPLIANCE 20 0.0004
735 BREAST CANCER 34 0.0004
736 VENTRICULAR TACHYCARDIA 6 0.0004
737 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
738 DENTAL CARIES 4 0.0004
739 VERTIGO 22 0.0004
740 AGEUSIA 9 0.0004
741 DEHYDRATION 48 0.0004
742 ILLNESS 37 0.0004
743 CHOKING 7 0.0004
744 INFLUENZA 40 0.0004
745 DRUG ADMINISTRATION ERROR 11 0.0004
746 MASS 5 0.0004
747 SNEEZING 8 0.0004
748 ADVERSE DRUG REACTION 32 0.0004
749 CIRCULATORY COLLAPSE 6 0.0004
750 PRURITUS 135 0.0004
751 PRESCRIBED UNDERDOSE 7 0.0004
752 SCAR 6 0.0004
753 MUSCULOSKELETAL DISCOMFORT 6 0.0003
754 FALL 116 0.0003
755 FULL BLOOD COUNT DECREASED 7 0.0003
756 MUSCLE TWITCHING 8 0.0003
757 INCORRECT DOSE ADMINISTERED 79 0.0003
758 PLEURAL EFFUSION 21 0.0003
759 MUSCULAR WEAKNESS 39 0.0003
760 JOINT STIFFNESS 9 0.0003
761 HYPERKALAEMIA 12 0.0003
762 CHILLS 40 0.0003
763 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
764 THIRST 6 0.0003
765 RASH 146 0.0003
766 HAEMORRHAGE INTRACRANIAL 5 0.0003
767 RASH PRURITIC 18 0.0003
768 BONE DISORDER 6 0.0003
769 NEURALGIA 8 0.0003
770 NO THERAPEUTIC RESPONSE 4 0.0003
771 IMPAIRED WORK ABILITY 7 0.0003
772 ABNORMAL DREAMS 9 0.0003
773 HYPOKALAEMIA 15 0.0003
774 DYSPHONIA 19 0.0003
775 PROCEDURAL PAIN 9 0.0003
776 EMOTIONAL DISORDER 10 0.0003
777 ACUTE MYELOID LEUKAEMIA 5 0.0003
778 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
779 BASAL CELL CARCINOMA 5 0.0003
780 NIGHTMARE 11 0.0003
781 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
782 ARRHYTHMIA 15 0.0003
783 RENAL FAILURE 42 0.0003
784 HEAD INJURY 10 0.0003
785 FLUSHING 32 0.0003
786 HYPERSOMNIA 9 0.0003
787 HYPOPHAGIA 8 0.0003
788 POLLAKIURIA 13 0.0003
789 GLAUCOMA 6 0.0003
790 MOVEMENT DISORDER 10 0.0003
791 ACCIDENTAL EXPOSURE TO PRODUCT 32 0.0003
792 ANOREXIA 4 0.0003
793 HYPOGLYCAEMIA 15 0.0003
794 BLOOD GLUCOSE INCREASED 58 0.0003
795 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
796 ORAL HERPES 6 0.0003
797 SWELLING FACE 20 0.0003
798 NODULE 4 0.0003
799 METASTASES TO BONE 5 0.0003
800 IMMUNE SYSTEM DISORDER 4 0.0003
801 SARS-COV-2 TEST POSITIVE 4 0.0003
802 HAEMATOCRIT DECREASED 6 0.0003
803 FLATULENCE 17 0.0003
804 BURNING SENSATION 21 0.0003
805 ARTHRALGIA 124 0.0003
806 FREQUENT BOWEL MOVEMENTS 8 0.0003
807 ACUTE HEPATIC FAILURE 4 0.0003
808 CORONARY ARTERY OCCLUSION 4 0.0003
809 LIMB DISCOMFORT 9 0.0003
810 HAEMATOCHEZIA 16 0.0003
811 ALOPECIA 56 0.0003
812 HYPONATRAEMIA 16 0.0003
813 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
814 PAIN IN JAW 8 0.0003
815 DRUG ERUPTION 5 0.0003
816 URINARY TRACT INFECTION 48 0.0003
817 PAIN 172 0.0003
818 RED BLOOD CELL COUNT DECREASED 8 0.0003
819 WEIGHT DECREASED 78 0.0003
820 CARDIOGENIC SHOCK 4 0.0003
821 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
822 HYPOKINESIA 4 0.0003
823 CRYING 10 0.0003
824 GASTROENTERITIS 4 0.0003
825 SUICIDAL IDEATION 25 0.0003
826 ERYTHEMA 56 0.0003
827 LABORATORY TEST ABNORMAL 8 0.0003
828 HAEMATOMA 7 0.0003
829 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
830 AGRANULOCYTOSIS 5 0.0003
831 MIDDLE INSOMNIA 5 0.0003
832 MUCOSAL INFLAMMATION 7 0.0003
833 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
834 APHASIA 8 0.0003
835 DEPRESSED MOOD 14 0.0003
836 LACRIMATION INCREASED 8 0.0003
837 DYSPHAGIA 25 0.0003
838 GASTRIC DISORDER 9 0.0003
839 CARDIAC FAILURE 21 0.0003
840 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 53 0.0003
841 DRUG DEPENDENCE 42 0.0003
842 BLOOD CREATININE INCREASED 17 0.0003
843 JAUNDICE 7 0.0003
844 DEVICE RELATED INFECTION 4 0.0003
845 HERNIA 5 0.0003
846 TENDONITIS 4 0.0003
847 LUNG INFECTION 4 0.0003
848 EJECTION FRACTION DECREASED 4 0.0003
849 HAEMORRHOIDS 5 0.0003
850 SKIN FISSURES 5 0.0003
851 KIDNEY INFECTION 5 0.0003
852 LYMPHADENOPATHY 9 0.0003
853 DIVERTICULITIS 7 0.0003
854 PRODUCT PRESCRIBING ERROR 6 0.0003
855 PREMATURE DELIVERY 4 0.0003
856 ABSCESS 4 0.0003
857 PRODUCT QUALITY ISSUE 34 0.0003
858 VISUAL IMPAIRMENT 31 0.0002
859 SPINAL FRACTURE 5 0.0002
860 CARDIAC FAILURE CONGESTIVE 20 0.0002
861 INTERSTITIAL LUNG DISEASE 12 0.0002
862 PAIN IN EXTREMITY 73 0.0002
863 OFF LABEL USE 216 0.0002
864 VISUAL ACUITY REDUCED 8 0.0002
865 WHITE BLOOD CELL COUNT DECREASED 26 0.0002
866 URINARY RETENTION 8 0.0002
867 SKIN DISCOLOURATION 11 0.0002
868 MOUTH ULCERATION 5 0.0002
869 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
870 HEMIPARESIS 4 0.0002
871 RENAL INJURY 7 0.0002
872 SKIN ULCER 6 0.0002
873 RASH GENERALISED 6 0.0002
874 ANAEMIA 44 0.0002
875 LOCAL SWELLING 4 0.0002
876 DYSGEUSIA 17 0.0002
877 BACK PAIN 53 0.0002
878 AMENORRHOEA 4 0.0002
879 NERVOUS SYSTEM DISORDER 7 0.0002
880 GALLBLADDER DISORDER 4 0.0002
881 BLOOD BILIRUBIN INCREASED 6 0.0002
882 SURGERY 13 0.0002
883 PULMONARY EMBOLISM 21 0.0002
884 HIP FRACTURE 7 0.0002
885 CONJUNCTIVITIS 4 0.0002
886 GASTROINTESTINAL HAEMORRHAGE 18 0.0002
887 EMOTIONAL DISTRESS 26 0.0002
888 HOT FLUSH 16 0.0002
889 INTESTINAL OBSTRUCTION 8 0.0002
890 STAPHYLOCOCCAL INFECTION 7 0.0002
891 RENAL FAILURE ACUTE 9 0.0002
892 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
893 COLITIS 8 0.0002
894 SKIN DISORDER 7 0.0002
895 FOETAL EXPOSURE DURING PREGNANCY 17 0.0002
896 BLOOD PRESSURE FLUCTUATION 5 0.0002
897 PANCREATITIS 11 0.0002
898 LOCALISED INFECTION 5 0.0002
899 DRUG WITHDRAWAL SYNDROME 18 0.0002
900 PLASMA CELL MYELOMA 8 0.0002
901 CEREBRAL INFARCTION 5 0.0002
902 HAEMOGLOBIN DECREASED 21 0.0002
903 ARTHRITIS 16 0.0002
904 DISEASE PROGRESSION 24 0.0002
905 ABASIA 5 0.0002
906 UPPER LIMB FRACTURE 4 0.0002
907 DEEP VEIN THROMBOSIS 13 0.0002
908 NEUROPATHY PERIPHERAL 19 0.0002
909 HAEMATEMESIS 5 0.0002
910 ERECTILE DYSFUNCTION 5 0.0002
911 INFLUENZA LIKE ILLNESS 16 0.0002
912 RENAL DISORDER 9 0.0002
913 TOOTH LOSS 4 0.0002
914 NEUTROPENIA 26 0.0002
915 DERMATITIS 4 0.0002
916 OCULAR HYPERAEMIA 9 0.0002
917 PLATELET COUNT DECREASED 20 0.0002
918 RECTAL HAEMORRHAGE 8 0.0002
919 FEAR 5 0.0002
920 PRURITUS GENERALISED 4 0.0002
921 CATARACT 11 0.0002
922 ADVERSE EVENT 17 0.0002
923 LIMB INJURY 5 0.0002
924 PRODUCT PRESCRIBING ISSUE 4 0.0002
925 ANGIOEDEMA 8 0.0002
926 DRY EYE 9 0.0002
927 THROMBOCYTOPENIA 20 0.0002
928 EYE PRURITUS 6 0.0002
929 MYALGIA 30 0.0002
930 THERAPY CESSATION 9 0.0002
931 HERPES ZOSTER 10 0.0002
932 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
933 DEVICE USE ERROR 6 0.0002
934 HEART RATE DECREASED 6 0.0002
935 PRODUCT DOSE OMISSION 11 0.0002
936 CEREBRAL HAEMORRHAGE 6 0.0002
937 SKIN BURNING SENSATION 12 0.0002
938 RASH ERYTHEMATOUS 8 0.0002
939 MALIGNANT NEOPLASM PROGRESSION 17 0.0002
940 WRONG TECHNIQUE IN DRUG USAGE PROCESS 6 0.0002
941 OSTEONECROSIS OF JAW 4 0.0002
942 EXPOSURE VIA SKIN CONTACT 4 0.0002
943 SKIN EXFOLIATION 13 0.0002
944 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
945 COGNITIVE DISORDER 7 0.0001
946 ANGER 5 0.0001
947 PRODUCT DOSE OMISSION ISSUE 43 0.0001
948 HAEMATURIA 5 0.0001
949 LUNG NEOPLASM MALIGNANT 6 0.0001
950 DEMENTIA 4 0.0001
951 EYE PAIN 8 0.0001
952 LEUKOPENIA 7 0.0001
953 EYE IRRITATION 8 0.0001
954 CARDIAC DISORDER 13 0.0001
955 DEVICE LEAKAGE 6 0.0001
956 LIVER FUNCTION TEST ABNORMAL 4 0.0001
957 ACUTE MYOCARDIAL INFARCTION 4 0.0001
958 COLITIS ULCERATIVE 6 0.0001
959 HAEMORRHAGE 14 0.0001
960 DIABETES MELLITUS 10 0.0001
961 RENAL IMPAIRMENT 11 0.0001
962 PSORIASIS 17 0.0001
963 FEMUR FRACTURE 4 0.0001
964 BONE DENSITY DECREASED 4 0.0001
965 THERAPY INTERRUPTED 9 0.0001
966 CYSTITIS 4 0.0001
967 HOSPITALISATION 19 0.0001
968 HYPOACUSIS 5 0.0001
969 DEVICE DISLOCATION 5 0.0001
970 THROMBOSIS 9 0.0001
971 SKIN IRRITATION 5 0.0001
972 CEREBROVASCULAR ACCIDENT 18 0.0001
973 INJECTION SITE ERYTHEMA 13 0.0001
974 MULTIPLE SCLEROSIS 5 0.0001
975 BLOOD GLUCOSE DECREASED 5 0.0001
976 DEVICE MALFUNCTION 7 0.0001
977 BLINDNESS 4 0.0001
978 MYOCARDIAL INFARCTION 17 0.0001
979 ECZEMA 5 0.0001
980 NEOPLASM MALIGNANT 6 0.0001
981 DEVICE ISSUE 8 0.0001
982 BONE PAIN 5 0.0001
983 DRUG EFFECT DECREASED 4 0.0001
984 DEPENDENCE 4 0.0001
985 ACNE 5 0.0001
986 INJECTION SITE SWELLING 5 0.0001
987 INJECTION SITE HAEMORRHAGE 5 0.0001
988 INJECTION SITE PAIN 19 0.0001
989 DRY SKIN 8 0.0001
990 INJECTION SITE PRURITUS 4 0.0001
991 INJECTION SITE BRUISING 4 0.0001
992 DRUG DOSE OMISSION 6 0.0000